Stay updated with breaking news from Csl Behring. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
US regulators approved CSL Behring's hemophilia B gene therapy, a one-off infusion that frees patients from regular treatments but costs $3.5 million a dose, making it the most expensive medicine in the world.
CSL Behring's hemophilia B gene therapy, Hemgenix, carries a $3.5 million list price. But the company contends that by reducing economic burdens associated with bleeding and prophylactic infusions, the one-time treatment will save money over time.
Following success of Hizentra App, CSL Behring and BrightInsight expand partnership to build apps for rare disease medicines across the globe...
MELBOURNE, Australia and KING OF PRUSSIA, Pennsylvania Pipeline advancements and investment in innovation and disruptive technologies to help fuel sustainable, profitable growth for CSL’s three businesses, CSL Behring, CSL Seqirus and CSL Vifor, in the decades ahead.
On Twitter and over email, Fetterman’s campaign manager Brendan McPhillips laid into what he called a “scam PAC” that was “using John’s name and likeness for their own fundraising.”